• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Meta-analysis effects of levosimendan on mortality and hemodynamics in patients with sepsis

    2023-11-23 09:47:58ZHAOMingruiZHENGRuiYANGYuanzheng
    Journal of Hainan Medical College 2023年13期
    關(guān)鍵詞:膿毒孟旦左西

    ZHAO Ming-rui, ZHENG Rui, YANG Yuan-zheng

    Emergency and Trauma College, Hainan Medical University, Haikou 571199, China

    Keywords:

    ABSTRACT Objective: To investigate the effect of levosimendan on 28-day mortality in patients with sepsis.Methods: The English databases including Embase, PubMed, Web of Science,Cochrane Library and Chinese databasesincluding China National Knowledge Infrastructure(NKI), Wan fang Data, VIP, CBM were searched with levosimendan, sepsis and septic shock is as search terms.The published clinical randomized controlled trials of levosimendan injection were searched and the primary outcome measures of 28-day and 30-day mortality were included.Secondary outcome measures were left ventricular ejection fraction, left ventricular work index, cardiac index, and lactic acid.The literature retrieved is from the establishment of the database to October 2022.Stata 14.0 software was used for all data consolidation,publication bias monitoring and sensitivity analysis.Results: A total of 15 studies with 1 337 patients were included in this meta-analysis.The results showed that at the 28-day mortality of patients with sepsis in the levosimendan group was not statistically superior to the 28-day mortality in the control group [RR=0.91, 95% CI(0.78~1.06), Z=1.24, P=0.22].However,levosimendan can increase left ventricular ejection fraction, decrease left ventricular function index, increase cardiac index and decrease lactic acid in patients with sepsis.Conclusion:There is insufficient evidence to support a reduction in 28-day mortality in sepsis patients with levosimendan.However, levosimendan showed positive results on hemodynamic parameters,and more clinical trials are needed to verify the application of levosimendan in hemodynamic parameters of sepsis.

    1.Introduction

    Sepsis is a disease in which infection leads to a systemic immune response that produces both pro-inflammatory and anti-inflammatory mechanisms, and coagulation interacts with the immune system and endothelium, resulting in impaired hemodynamics and ultimately multiple organ dysfunction[1].When inflammatory factors, including cytokines, nitric oxide, complement system and lipopolysaccharide (LSP), act on myocardial cells,cardiac function is inhibited[2].Septic cardiomyopathy SCM was first described in 1958, and it still lacks a clear and consistent definition.The most common definition is reversible myocardial dysfunction due to sepsis, characterized by LVFE< 50% as diagnostic criteria, left ventricular dilation, and early return to normal clinical status[3].In addition, it has been found that the activation of toll-like receptors (TLRS), nuclear factor KB,mitochondrial dysfunction, endothelial dysfunction, autonomic nervous regulation and other aspects are associated with sepsis cardiomyopathy (SCM), but the specific pathogenesis remains unclear[4].According to existing studies, septic cardiomyopathy can be defined as an acute syndrome of cardiac dysfunction associated with sepsis and unrelated to myocardial ischemia, but there is still a lack of clear diagnostic criteria and strict evidence-based medicine definition of septic cardiomyopathy[5].

    Levosimendan is calcium ion sensitizer, a new type of positive inotropic drugs.Compared with positive inotropic drugs,levosimendan does not increase the concentration of Ca2+in cardiomyocytes, but plays a strong role through the sensitivity of myocardial contractile proteins to Ca2+, so it is called calcium sensitizer[6].Therefore, levosimendan did not increase the influx of Ca2+in cardiomyocytes during excitatory systolic coupling, nor did it affect the diastolic function of myocardium due to the obstruction of outflow of Ca2+in cardiomyocytes due to the increase of intracellular Ca2+[7].Currently, it is widely used in acute heart failure patients with poor therapeutic effect of traditional positive inotropic drugs, and can also be used in the treatment of cardiogenic shock, pulmonary hypertension, perioperative cardiac surgery and other diseases.In the 2021 International Guidelines for the Management of Sepsis and Septic Shock, dobutamine is recommended to be added to norepinephrine and levosimendan is not recommended for patients with septic shock and cardiac insufficiency when volume and arterial pressure are sufficient.This recommendation is presented as weak and of low quality evidence [8].However, compared with dobutamine in the treatment of sepsis and septic shock, the improvement of mortality and cardiac function indicators is still controversial.A comparative study of levosimendan versus dobutamine or a blank control group was conducted to evaluate the clinical effect of levosimendan on 28-day mortality and hemodynamics.To provide reference for clinical treatment from the perspective of evidencebased medicine.

    2.Data and methods

    2.1 Selection of documents

    Inclusion criteria: (1) Subjects were >18 years old and diagnosed as meeting international or Chinese guidelines for the treatment of sepsis or septic shock;(2) no contraindications to levosimendan application; (2) Levosimendan was applied in the intervention group;The control group was other positive inotropic drugs or other blank controls.There is no dose schedule or time limit for infusion; (3)Study type: randomized controlled trial; (4) Report 28-day mortality or 30-day mortality data.

    Exclusion criteria: (1) duplication;(2) animal experiments or in vitro studies;(3) Patients with sepsis or septic shock were not clearly diagnosed;(4) Excluding the use of positive inotropic drugs or combined with adult drugs except levosimendan; (5) Conference articles and master and erudite papers.

    2.2 Literature retrieval strategy

    References were obtained from two researchers who independently searched the following databases: CNKI, Wanfang Data, VIP, China Biomedical Literature Database, Embase, PubMed, Web of Science,and Cochrane library.The search time was updated from the database to October 1, 2022.There are no language restrictions.In addition, references included in the study and related meta-analysis were tracked to supplement the relevant literature.The retrieved literature was imported into Noteexpress literature management software, and duplicates and non-randomized controlled studies were eliminated according to the title and abstract of the literature.Unable to judge the literature, further reading the full text of literature to screen out the literature meeting the inclusion criteria.Consult with the third researcher in case of inclusion disagreements.

    Search the above database by the combination of subject words and free words.Chinese search terms include:休克,膿毒性、膿毒癥、膿毒血癥、膿毒性休克、感染性休克、左西孟旦、隨機(jī)對(duì)照試驗(yàn)、隨機(jī)對(duì)照實(shí)驗(yàn)、隨機(jī)對(duì)照研究。English search terms include:Sepsis, Bloodstream Infection,Bloodstream Infections,Infection, Bloodstream, Pyemia, Simendan,Levosimendan, Randaomized controlled trialetc.

    2.3 Literature quality evaluation

    The included literature was assessed independently by two investigators using the Cochrane risk bias assessment tool.The evaluation included whether random allocation was used, whether the allocation scheme was hidden, whether blind, whether there was selective reporting of research results, and whether there were other sources of migration.

    2.4 data extraction

    The required data were extracted from the included literature: (1)basic literature information: first author and publication date;(2)Basic information of the subjects (age, gender, diagnosis and the number of experimental group and control group);(3) Intervention measures (drug name, dosage and duration of infusion used in experimental group and control group);(4) Outcome indicators:primary outcome indicators (28-day mortality or 30-day mortality),secondary outcome indicators (left ventricular ejection fraction, left ventricular work index, cardiac index, lactic acid).

    2.5 statistical method

    Stata MP 14 software was used for statistical analysis and forest map drawing.Relative risk (RR) and 95% confidence interval were used to represent the biclassification data.Continuity variables were represented by weighted mean difference (WMD) and 95%confidence interval (CI) Q test was used to test the heterogeneity of each study.IfI2of Q test is less than 50%, andP>0.1 of Q test,it is considered that all studies are homogeneous, and fixed-effect model is used for analysis.IfI2of Q test is greater than 50% andP<0.1, heterogeneity is considered in all studies, and random effects model is adopted for analysis[9].The Stata MP 14 software was used to determine whether publication bias existed in Egger’s linear regression quantitative detection and evaluation.IfP<0.05 suggested publication bias, shear and supplement method and single study examination were used for sensitivity analysis.IfP>0.05 indicates no significant publication bias, the results are reliable.

    3.Result

    3.1 Literature search results

    A total of 345 articles were obtained according to the search strategy.There were 172 duplicate literatures, 69 reviews and systematic reviews, 12 animal experiments, 7 conference papers and graduation papers, 73 literatures with inconsistent research content and experimental design were excluded, 3 literatures with inclusion criteria were obtained through other channels, and 15 literatures were finally included in the meta-analysis.A total of 1337 patients were enrolled, of which 672 were enrolled in the experimental group(levosimendan group) and 665 were enrolled in the control group(other positive inotropic agents or placebo) (Figure 1).The literature was evaluated according to the Cochrane risk Bias assessment tool(Figure 2).

    Both Roald Dahl s poem of the tale and Stephen Sondheim s musical, Into the Woods, have Red Riding Hood overcome the wolf and later appear wearing a fur coat made of the wolf s fur, instead of the identifying red cloak.

    Fig 1 Flow chart in literature inclusion

    3.2 Results of meta-analysis

    3.2.1 28-day mortality analysis

    Fifteen articles reported 28-day mortality rates between levosimendan and the control group, and two articles reported 30-day mortality rates.The results showed that the 28-day mortality of sepsis patients in the levosimendan group was not statistically superior to that in the control group (Fixed effect RR=0.91, 95%confidence interval [CI] [0.78-1.06],Z=1.24,P=0.22>0.05) (Figure 3, 4).

    Tab 1 Characteristics of included literature

    Fig 2 Quality assessment of the included literature

    3.2.2 Left ventricular ejection fraction (LVEF) analysis

    Left ventricular ejection fraction (LVEF) of levosimendan and control group was reported in 10 literatures.The results showed that the left ventricular ejection fraction of patients with sepsis in levosimendan group was statistically different from that in control group, and the intervention effect was significant.(Fixed effect WMD=5.328, 95% confidence interval [CI] [4.19-6.47],Z=9.17,P=0.000<0.05) (Figure 5).

    3.2.3 Left ventricular work index (LVSWI) analysis

    The left ventricular work index (LVSWI) of levosimendan and control group was reported in 4 literatures.The results showed that LVSWI in the treatment of sepsis patients in levosimendan group was statistically different from that in the control group, and the intervention effect was significant.(Random effects WMD=4.458,95% confidence interval [CI] [2.98-5.93],Z=5.92,P=0.000<0.05)(Figure 6).

    3.2.4 Cardiac index (CI) analysis

    Cardiac index (CI) of levosimendan and control group was reported in 7 literatures.The results showed that the CI of the levosimendan group in the treatment of sepsis patients was statistically significant compared with the control group.(Random effectsWMD=0.507, 95%confidence interval [CI] [0.33-0.68],Z=5.71,P=0.000<0.05) (Figure 7).

    3.2.5 Lactic acid (Lac) analysis

    Lactic acid results (Lac) of levosimendan and control group were reported in seven articles.According to the results of meta-analysis,Lac in the treatment of sepsis patients in levosimendan group was statistically different from that in the control group (fixed effectsWMD= 0.969, 95% confidence interval [CI] (1.23 ~ 0.71),Z= 7.27,P= 0.000 < 0.05) (figure 8).

    Fig 3 Forest map of 28-day mortality

    Fig 4 Funnel plot of 28-day mortality

    Fig 5 Forest map of left ventricular ejection fraction (LVEF)

    Fig 6 Forest map of left ventricular work index (LVSWI)

    3.3 Publication bias evaluation

    The publication bias of 15 articles included in the evaluation of the influence of levosimmondal on the 28-day mortality of sepsis patients was roughly symmetrical in the distribution of funnel plot scatter points, and the Egger’s test was used to quantitatively evaluate publication bias, andP=0.015<0.05 was obtained, indicating the existence of publication bias.The shear supplement method was further used to further test the publication bias.No virtual shear supplement literature or data was added to the corrected results by the shear supplement method.At the same time, a single study wasused to assess the impact of each included article on the 28-day mortality outcome, and the results showed that the combined association and inter-study heterogeneity after excluding any article had little effect on the total combined effect size, and the results were reliable and acceptable (Figure 9, 10).

    Fig 8 Forest map of lactic acid (Lac)

    To evaluate the bias of the results of 10 articles included in the secondary outcome index LVEF, the funnel plot scatter distribution was roughly symmetrical, and the Egger’s test was used to evaluate publication bias quantitatively, andP=0.814 > 0.05 was obtained,indicating a stable result (Figure 11).

    To evaluate the bias of the results of 7 articles included in the secondary outcome index CI, the funnel plot scatter distribution was roughly symmetrical, and the Egger’s test was used to evaluate publication bias quantitatively, andP=0.205 > 0.05 was obtained,indicating a stable result (Figure 12).

    To evaluate the bias of 7 articles included in Lac, the funnel plot scatter distribution was roughly symmetrical, and the Egger’s test was used to evaluate publication bias quantitatively, andP=0870 >0.05 was obtained, indicating a stable result.

    Fig 9 Correction chart of 28-day mortality by shear supplement method

    Fig 10 Impact assessment of a single study on 28-day mortality

    Fig 11 Egger’s test of LVEF

    Fig 12 Egger’s test of CI

    Fig 13 Egger’s test of Lac

    4.Discussion

    4.1 Effect of levosimendan injection on mortality

    In this study, 15 literatures with 28-day mortality or 30-day mortality as primary outcome indicators were included (all randomized controlled studies).A meta-analysis was used to conduct a comprehensive quantitative analysis of Levosimendan injection on mortality.There was no significant difference in mortality outcomes at 28 days between the treatment group (levosimendan) and the control group (conventional therapy or other positive inotropic drugs).Levosimendan showed no significant difference in the 28-day mortality of sepsis patients compared with the control group.The conclusion was consistent with the meta-analysis published by Fang Feng[25] et al in 2019 and Guo Qingqing[26] et al in 2021.Levosimendan could not reduce the mortality of sepsis patients,which was consistent with the conclusion of this study.However,In a meta-analysis by Zangrillo[27] et al., levosimendan was associated with significantly reduced mortality in patients with septic shock compared to standard positive inotropic drug therapy.Yang Chunbo[28]et al.found in a meta-analysis study on the clinical efficacy of patients with septic cardiomyopathy that levosimendan could reduce the mortality of patients with septic cardiomyopathy compared with dobutamine.The reasons for the different results may be that the included literature and research objects are different,and the statistical methods used are slightly different.Therefore,more prospective multi-center clinical studies are needed for further research to increase the evidence-based medical basis.

    In terms of the influence of levosimendan on hemodynamic indexes, the results showed that the left ventricular ejection fraction(LVEF), left ventricular work index (LVSWI), heart index (CI)and lactic acid (Lac) of sepsis patients had significant statistical differences compared with the control group.In other words,levosimendan can increase left ventricular ejection fraction, decrease left ventricular function index, increase cardiac index, and decrease lactic acid in sepsis patients compared with other positive inotropic drugs or conventional therapy.In 2010, Bergh et al.[29] conducted a randomized double-blind clinical study on patients with acute onset chronic heart failure, comparing levosimendan with dobutamine,and the results showed that the hemodynamic improvement in the levosimendan infusion group was due to dobutamine.In a prospective single-center study on the hemodynamics of levosimendan on end-stage stable heart failure, Emil et al.[30] found that levosimendan was associated with improved hemodynamics in study subjects.The above literature showed positive significance for the hemodynamic outcome of levosimendan in patients with heart failure.In addition, a retrospective study published by Hu Aihao[31] et al.in 2021 on the effects of levosimendan combined with recombinant human brain natriuretic peptide for injection on left heart function and hemodynamics in septic shock patients showed that levosimendan combined with recombinant human brain natriuretic peptide for injection could improve left heart function and hemodynamics in septic shock patients.Levosimendan has been poorly studied in the treatment of sepsis and septic shock, and still shows a positive advantage over other positive inotropic drugs in the published literature, which is consistent with the results of this study.However, more clinical data are needed for further and specific research results.

    Limitations of this meta-analysis: the sample size of most of the included articles was small, and the proportion of patients studied in one article accounted for one-third of the total number of Meta articles.This may lead to deviations between the final results and the actual clinical situation and experimental results.For the main outcome indicators, some studies used 28-day mortality, some used 30-day mortality, and different outcome indicators data may also have biases on the results of the study.In addition, the drugs used in the control group were different, including dobutamine, conventional treatment group and epinephrine.The types of drugs used, dosages and drip rates of drugs were different, which would also cause deviations in the results.Among the secondary outcome indicators,there were differences in the time of data collection and recording.The experimental data came from different time after enrollment,such as 24 h, 48 h and 72 h.Meanwhile, the number of studies and experiments that could be included in the secondary outcome indicators was small, which may lead to the deviation in the results.Therefore, more prospective multi-center clinical trials are needed to further improve the efficacy of levosimendan in patients with sepsis and septic shock.

    In summary, compared with dobutamine or conventional treatment,levosimendan could not reduce the mortality of sepsis patients,but could increase LVEF and CI, and decrease LVSWI and Lac.However, the sample size of this meta-analysis is insufficient and there is a lack of high-quality literature support.The conclusions obtained need more clinical data support, and should also be used with caution in clinical application.The application of levosimendan in septic cardiomyopathy still needs further exploration in the future.

    猜你喜歡
    膿毒孟旦左西
    MMP-9對(duì)急性呼吸窘迫綜合征并膿毒性休克患者的早期診斷及預(yù)后評(píng)估價(jià)值研究
    血清NGAL聯(lián)合乳酸及APACHE Ⅱ評(píng)分對(duì)膿毒性休克合并急性腎損傷患者病死的預(yù)測(cè)價(jià)值
    左西孟旦治療重癥冠心病所致心衰的臨床療效
    急性心肌梗死伴心力衰竭患者行左西孟旦治療的臨床療效
    左西孟旦聯(lián)合無(wú)創(chuàng)正壓通氣治療急性心肌梗死后急性左心衰竭的效果觀察
    β受體阻滯劑在膿毒性休克中的應(yīng)用研究進(jìn)展
    西替利嗪與左西替利嗪對(duì)大鼠氨茶堿血藥濃度的影響
    左西孟旦治療急性失代償性心力衰竭的效果評(píng)價(jià)
    中西醫(yī)結(jié)合治療糖尿病并發(fā)癰疽合膿毒敗血癥驗(yàn)案2則
    一级毛片久久久久久久久女| 国产精品不卡视频一区二区| 永久网站在线| 亚洲欧洲国产日韩| 久久韩国三级中文字幕| 久久精品久久久久久久性| 精品一品国产午夜福利视频| 22中文网久久字幕| xxx大片免费视频| 王馨瑶露胸无遮挡在线观看| 久久久久久久国产电影| 人人妻人人澡人人爽人人夜夜| 街头女战士在线观看网站| 又粗又硬又长又爽又黄的视频| 国模一区二区三区四区视频| 久久精品国产亚洲av天美| 在线精品无人区一区二区三 | 妹子高潮喷水视频| 麻豆成人av视频| 亚洲精品亚洲一区二区| 舔av片在线| 乱系列少妇在线播放| 最近最新中文字幕大全电影3| 伦理电影大哥的女人| 欧美日韩在线观看h| 狂野欧美激情性xxxx在线观看| 在线免费十八禁| 一个人免费看片子| 国产精品一区二区性色av| 日日撸夜夜添| 五月天丁香电影| 丝袜喷水一区| 成人毛片60女人毛片免费| 成人国产av品久久久| 搡女人真爽免费视频火全软件| 综合色丁香网| 精品99又大又爽又粗少妇毛片| 99国产精品免费福利视频| 免费高清在线观看视频在线观看| 一级毛片久久久久久久久女| 国产欧美日韩一区二区三区在线 | h视频一区二区三区| 午夜福利在线观看免费完整高清在| 少妇人妻久久综合中文| 王馨瑶露胸无遮挡在线观看| 免费少妇av软件| 亚洲电影在线观看av| 少妇人妻久久综合中文| 女性被躁到高潮视频| 最近最新中文字幕大全电影3| 精品国产一区二区三区久久久樱花 | 午夜免费鲁丝| 狠狠精品人妻久久久久久综合| 成人高潮视频无遮挡免费网站| 欧美精品一区二区免费开放| 久久国产亚洲av麻豆专区| 如何舔出高潮| 国产高清不卡午夜福利| 亚洲国产欧美在线一区| 秋霞在线观看毛片| 99re6热这里在线精品视频| 黄片无遮挡物在线观看| 久久97久久精品| 91精品国产九色| 赤兔流量卡办理| 国产精品一区二区在线观看99| 黑丝袜美女国产一区| 你懂的网址亚洲精品在线观看| 亚洲电影在线观看av| 日韩欧美 国产精品| 在线观看av片永久免费下载| 亚洲成人中文字幕在线播放| 日韩中文字幕视频在线看片 | 免费看av在线观看网站| 国产真实伦视频高清在线观看| 日韩精品有码人妻一区| 免费观看的影片在线观看| 国产成人a区在线观看| 男女免费视频国产| 又粗又硬又长又爽又黄的视频| 在现免费观看毛片| 日韩欧美一区视频在线观看 | 免费av中文字幕在线| 熟女人妻精品中文字幕| 人妻一区二区av| 日本与韩国留学比较| 国产真实伦视频高清在线观看| 最黄视频免费看| 91久久精品电影网| 亚洲欧美成人综合另类久久久| 免费观看性生交大片5| 久久国内精品自在自线图片| 免费看av在线观看网站| 日韩一区二区视频免费看| 亚洲av不卡在线观看| 精品亚洲成a人片在线观看 | 久久久久性生活片| 亚洲中文av在线| 最黄视频免费看| 大片免费播放器 马上看| 精品亚洲乱码少妇综合久久| 在线看a的网站| 国产亚洲欧美精品永久| 麻豆精品久久久久久蜜桃| 99re6热这里在线精品视频| 少妇被粗大猛烈的视频| 婷婷色综合www| 成人美女网站在线观看视频| freevideosex欧美| 一二三四中文在线观看免费高清| 一级爰片在线观看| 国产精品国产三级专区第一集| 丰满迷人的少妇在线观看| 香蕉精品网在线| 少妇高潮的动态图| 啦啦啦在线观看免费高清www| 婷婷色综合www| 婷婷色av中文字幕| 中文字幕免费在线视频6| 蜜臀久久99精品久久宅男| 大码成人一级视频| 一级毛片我不卡| 狠狠精品人妻久久久久久综合| 国产黄片美女视频| 成人黄色视频免费在线看| 欧美少妇被猛烈插入视频| 日本一二三区视频观看| 亚洲精品一区蜜桃| 九九在线视频观看精品| 97超视频在线观看视频| 毛片女人毛片| 伊人久久国产一区二区| 精品国产一区二区三区久久久樱花 | 免费观看av网站的网址| 亚洲av.av天堂| 欧美zozozo另类| 美女视频免费永久观看网站| 亚洲,欧美,日韩| 91午夜精品亚洲一区二区三区| 九色成人免费人妻av| 我要看黄色一级片免费的| 国产深夜福利视频在线观看| 欧美+日韩+精品| 男的添女的下面高潮视频| 国产精品欧美亚洲77777| 成年人午夜在线观看视频| 少妇精品久久久久久久| 国产在线免费精品| 婷婷色麻豆天堂久久| 欧美精品国产亚洲| 免费看日本二区| 国产精品一区二区三区四区免费观看| 大码成人一级视频| 纯流量卡能插随身wifi吗| 欧美日韩综合久久久久久| 亚洲内射少妇av| 麻豆精品久久久久久蜜桃| 国产精品一区二区三区四区免费观看| 多毛熟女@视频| 嘟嘟电影网在线观看| .国产精品久久| 一边亲一边摸免费视频| 欧美成人午夜免费资源| 午夜福利在线在线| 国产成人免费无遮挡视频| 最近最新中文字幕大全电影3| 91午夜精品亚洲一区二区三区| 国产黄片视频在线免费观看| 精品一区二区三卡| 精品久久久久久久久亚洲| 亚洲va在线va天堂va国产| 精品一品国产午夜福利视频| 九九久久精品国产亚洲av麻豆| 一本一本综合久久| 日韩,欧美,国产一区二区三区| 亚洲国产av新网站| 久久久久性生活片| 成年美女黄网站色视频大全免费 | 99久久精品热视频| 国产乱来视频区| 看十八女毛片水多多多| 欧美精品国产亚洲| 亚洲不卡免费看| 身体一侧抽搐| 国产成人免费无遮挡视频| 欧美一级a爱片免费观看看| 亚洲精品视频女| 啦啦啦视频在线资源免费观看| 国产高清三级在线| 少妇丰满av| 亚洲四区av| 亚洲无线观看免费| 国产男人的电影天堂91| 欧美日韩亚洲高清精品| 国产永久视频网站| 亚洲婷婷狠狠爱综合网| 99re6热这里在线精品视频| 色吧在线观看| 国产精品久久久久久久久免| 国产永久视频网站| 免费观看的影片在线观看| 国产成人一区二区在线| 又粗又硬又长又爽又黄的视频| 免费看日本二区| 亚洲欧美一区二区三区黑人 | 热re99久久精品国产66热6| av福利片在线观看| 国产日韩欧美在线精品| 日韩人妻高清精品专区| 亚洲综合精品二区| 五月开心婷婷网| 一级片'在线观看视频| 成人二区视频| 成人毛片a级毛片在线播放| 久久精品久久精品一区二区三区| 最近最新中文字幕大全电影3| 一区二区三区精品91| 97热精品久久久久久| 欧美变态另类bdsm刘玥| 各种免费的搞黄视频| 国产精品一二三区在线看| 熟女电影av网| 久久97久久精品| av专区在线播放| 国产精品av视频在线免费观看| 国产 精品1| 岛国毛片在线播放| av一本久久久久| 久久精品国产a三级三级三级| 久久久久久九九精品二区国产| 久久国产亚洲av麻豆专区| 午夜视频国产福利| 大码成人一级视频| av黄色大香蕉| 日韩中字成人| 久久久久性生活片| 国产爱豆传媒在线观看| 大香蕉97超碰在线| 亚洲经典国产精华液单| 狂野欧美激情性xxxx在线观看| 精品亚洲乱码少妇综合久久| 国产精品无大码| 久久久久网色| 高清午夜精品一区二区三区| 91精品伊人久久大香线蕉| 亚洲精华国产精华液的使用体验| 午夜激情久久久久久久| 尤物成人国产欧美一区二区三区| 观看av在线不卡| 中文乱码字字幕精品一区二区三区| 久久鲁丝午夜福利片| 日本猛色少妇xxxxx猛交久久| 国产久久久一区二区三区| 日韩av在线免费看完整版不卡| av国产久精品久网站免费入址| 中文资源天堂在线| 精品久久国产蜜桃| 久久国产精品男人的天堂亚洲 | 又爽又黄a免费视频| 欧美亚洲 丝袜 人妻 在线| 婷婷色综合www| 人妻制服诱惑在线中文字幕| 国产综合精华液| 国产免费又黄又爽又色| 少妇丰满av| 久久久久性生活片| 亚洲精品视频女| av不卡在线播放| 亚洲中文av在线| 成人漫画全彩无遮挡| 亚洲人成网站高清观看| 精品久久久久久电影网| 超碰97精品在线观看| 午夜福利网站1000一区二区三区| 美女内射精品一级片tv| 久久久久国产网址| 国产综合精华液| 日韩欧美一区视频在线观看 | 一本久久精品| 成人亚洲精品一区在线观看 | 久久精品熟女亚洲av麻豆精品| 亚洲av成人精品一二三区| 麻豆乱淫一区二区| 91午夜精品亚洲一区二区三区| 国产精品久久久久成人av| 九草在线视频观看| 日本av手机在线免费观看| 成人一区二区视频在线观看| 国产精品人妻久久久影院| 亚洲图色成人| 日本av免费视频播放| 国产淫片久久久久久久久| 老司机影院毛片| 视频中文字幕在线观看| 色5月婷婷丁香| 免费久久久久久久精品成人欧美视频 | 十八禁网站网址无遮挡 | 国产乱来视频区| 国产高潮美女av| av国产久精品久网站免费入址| 日本黄色日本黄色录像| 色视频在线一区二区三区| 久久毛片免费看一区二区三区| 一本色道久久久久久精品综合| 特大巨黑吊av在线直播| 精品久久久久久久久亚洲| 国产视频内射| 亚洲精品久久久久久婷婷小说| 国产片特级美女逼逼视频| 99视频精品全部免费 在线| 一二三四中文在线观看免费高清| www.av在线官网国产| 亚洲av电影在线观看一区二区三区| 在线观看免费视频网站a站| 日韩中文字幕视频在线看片 | 欧美国产精品一级二级三级 | 永久免费av网站大全| 国模一区二区三区四区视频| 色网站视频免费| 卡戴珊不雅视频在线播放| 国产毛片在线视频| 视频中文字幕在线观看| 十八禁网站网址无遮挡 | 啦啦啦啦在线视频资源| 日韩av不卡免费在线播放| 中文乱码字字幕精品一区二区三区| 高清午夜精品一区二区三区| 中文字幕精品免费在线观看视频 | 国产淫片久久久久久久久| 你懂的网址亚洲精品在线观看| 好男人视频免费观看在线| 精品酒店卫生间| 青青草视频在线视频观看| 少妇的逼水好多| 一级片'在线观看视频| 又黄又爽又刺激的免费视频.| 日韩精品有码人妻一区| 国产久久久一区二区三区| 久久精品久久久久久噜噜老黄| 啦啦啦啦在线视频资源| 成人黄色视频免费在线看| 日本黄色片子视频| 亚洲熟女精品中文字幕| 极品教师在线视频| 深夜a级毛片| 国产69精品久久久久777片| 久久精品人妻少妇| 亚洲欧美日韩另类电影网站 | 日韩欧美精品免费久久| 最近中文字幕2019免费版| 王馨瑶露胸无遮挡在线观看| 九九在线视频观看精品| 国内精品宾馆在线| 身体一侧抽搐| a 毛片基地| 交换朋友夫妻互换小说| 欧美xxxx性猛交bbbb| 纵有疾风起免费观看全集完整版| 男人爽女人下面视频在线观看| 成年美女黄网站色视频大全免费 | 久久国产亚洲av麻豆专区| 国产欧美亚洲国产| 亚洲高清免费不卡视频| 成人亚洲欧美一区二区av| 91久久精品国产一区二区成人| 精品少妇黑人巨大在线播放| 国产黄片视频在线免费观看| 成人免费观看视频高清| 精品久久久久久久末码| 人人妻人人澡人人爽人人夜夜| 午夜福利视频精品| 国产亚洲午夜精品一区二区久久| 联通29元200g的流量卡| 欧美少妇被猛烈插入视频| 国产在线男女| 美女xxoo啪啪120秒动态图| 国产精品不卡视频一区二区| 天美传媒精品一区二区| www.av在线官网国产| 久久 成人 亚洲| 国产欧美亚洲国产| 国产免费一区二区三区四区乱码| 肉色欧美久久久久久久蜜桃| 麻豆成人午夜福利视频| 亚洲精品久久久久久婷婷小说| 日韩一区二区三区影片| 亚洲成人中文字幕在线播放| 亚洲不卡免费看| 99久久精品热视频| 国产日韩欧美在线精品| 少妇的逼好多水| 久热这里只有精品99| 精品一区在线观看国产| 国产毛片在线视频| 一二三四中文在线观看免费高清| 成人亚洲欧美一区二区av| 18禁裸乳无遮挡免费网站照片| 美女脱内裤让男人舔精品视频| 日本一二三区视频观看| 午夜福利高清视频| 韩国av在线不卡| 欧美精品一区二区免费开放| 成年av动漫网址| 亚洲欧洲国产日韩| 又黄又爽又刺激的免费视频.| 黑人高潮一二区| 在线亚洲精品国产二区图片欧美 | 永久免费av网站大全| 国产亚洲欧美精品永久| 亚洲国产精品国产精品| av在线观看视频网站免费| 高清欧美精品videossex| 久久久久久久久久成人| 日韩大片免费观看网站| 女的被弄到高潮叫床怎么办| av网站免费在线观看视频| 日本爱情动作片www.在线观看| 一级爰片在线观看| 亚洲国产精品专区欧美| 99热这里只有是精品50| 久久久精品94久久精品| 国产伦在线观看视频一区| 免费观看性生交大片5| 国产白丝娇喘喷水9色精品| 日韩欧美精品免费久久| 日韩欧美 国产精品| 一级黄片播放器| 久久99精品国语久久久| 美女视频免费永久观看网站| www.色视频.com| 欧美一级a爱片免费观看看| 97在线视频观看| 在线播放无遮挡| 久久青草综合色| 国产精品.久久久| 97热精品久久久久久| 永久网站在线| 麻豆乱淫一区二区| 亚洲精品乱码久久久久久按摩| 亚洲av成人精品一区久久| 色网站视频免费| av卡一久久| 亚洲,欧美,日韩| 亚洲精品国产色婷婷电影| 精品视频人人做人人爽| 一本色道久久久久久精品综合| 国产成人精品婷婷| 在线亚洲精品国产二区图片欧美 | a级毛片免费高清观看在线播放| 日日啪夜夜爽| 日本与韩国留学比较| 久久久久网色| 国产精品.久久久| 一区二区三区四区激情视频| 久久亚洲国产成人精品v| 欧美另类一区| av视频免费观看在线观看| 精品久久国产蜜桃| 又黄又爽又刺激的免费视频.| 日韩精品有码人妻一区| 欧美 日韩 精品 国产| 国产精品福利在线免费观看| 色视频www国产| 亚洲精品久久久久久婷婷小说| 免费黄色在线免费观看| 人妻夜夜爽99麻豆av| 亚洲四区av| 欧美xxⅹ黑人| 一区二区三区乱码不卡18| 三级经典国产精品| 免费大片18禁| 中文字幕久久专区| 亚洲国产av新网站| 国产精品蜜桃在线观看| 亚洲欧美精品专区久久| 久久久久国产精品人妻一区二区| 男女免费视频国产| 国产精品久久久久成人av| 99re6热这里在线精品视频| 激情 狠狠 欧美| 国产精品国产av在线观看| 中文精品一卡2卡3卡4更新| 中文在线观看免费www的网站| 国产精品av视频在线免费观看| 亚洲精品国产av蜜桃| 国产真实伦视频高清在线观看| 三级国产精品片| 91午夜精品亚洲一区二区三区| 下体分泌物呈黄色| 国产免费福利视频在线观看| 免费观看的影片在线观看| 国产有黄有色有爽视频| 王馨瑶露胸无遮挡在线观看| 看十八女毛片水多多多| 少妇猛男粗大的猛烈进出视频| 女性生殖器流出的白浆| 国产高清有码在线观看视频| 日韩国内少妇激情av| 女人十人毛片免费观看3o分钟| 美女脱内裤让男人舔精品视频| 最近的中文字幕免费完整| 日本色播在线视频| 亚洲第一av免费看| 久久久久久久精品精品| 成年美女黄网站色视频大全免费 | 我要看黄色一级片免费的| 国产黄色免费在线视频| 欧美高清性xxxxhd video| 少妇的逼好多水| 久久精品国产亚洲av涩爱| 春色校园在线视频观看| 男女啪啪激烈高潮av片| 99热这里只有精品一区| 色哟哟·www| 久久鲁丝午夜福利片| 国内精品宾馆在线| 亚洲天堂av无毛| 免费黄频网站在线观看国产| 激情 狠狠 欧美| av天堂中文字幕网| 一级黄片播放器| 精品一区二区免费观看| 国产精品人妻久久久久久| 欧美成人a在线观看| 永久免费av网站大全| 美女视频免费永久观看网站| xxx大片免费视频| 99re6热这里在线精品视频| 高清欧美精品videossex| 久久99蜜桃精品久久| 伊人久久国产一区二区| 搡老乐熟女国产| 大陆偷拍与自拍| 最近的中文字幕免费完整| 草草在线视频免费看| 免费人成在线观看视频色| 久久6这里有精品| 三级国产精品欧美在线观看| 18禁动态无遮挡网站| 2018国产大陆天天弄谢| 性高湖久久久久久久久免费观看| av女优亚洲男人天堂| 少妇被粗大猛烈的视频| h视频一区二区三区| 少妇猛男粗大的猛烈进出视频| 久久久久久九九精品二区国产| 国产91av在线免费观看| 97在线视频观看| 久久女婷五月综合色啪小说| 国产黄色视频一区二区在线观看| 草草在线视频免费看| 国产成人午夜福利电影在线观看| 日韩欧美精品免费久久| 日本与韩国留学比较| 99热这里只有是精品50| av在线播放精品| 成人毛片60女人毛片免费| 欧美极品一区二区三区四区| 多毛熟女@视频| 免费av不卡在线播放| 少妇 在线观看| 亚洲av男天堂| 亚洲精品日韩在线中文字幕| 精品亚洲乱码少妇综合久久| 99九九线精品视频在线观看视频| 欧美日韩一区二区视频在线观看视频在线| 欧美3d第一页| 2018国产大陆天天弄谢| 人人妻人人澡人人爽人人夜夜| 99热全是精品| 一本色道久久久久久精品综合| 一个人看视频在线观看www免费| 国产片特级美女逼逼视频| 视频区图区小说| 日韩在线高清观看一区二区三区| 一本久久精品| 亚洲成人中文字幕在线播放| 久热这里只有精品99| 亚洲国产最新在线播放| 日本av免费视频播放| 大又大粗又爽又黄少妇毛片口| 女人十人毛片免费观看3o分钟| 男女边摸边吃奶| 国产 一区 欧美 日韩| 最近中文字幕高清免费大全6| 午夜福利高清视频| 中文字幕人妻熟人妻熟丝袜美| 丰满迷人的少妇在线观看| 在线看a的网站| 亚洲精品乱码久久久v下载方式| 我要看日韩黄色一级片| 寂寞人妻少妇视频99o| 蜜桃久久精品国产亚洲av| 国产精品爽爽va在线观看网站| 肉色欧美久久久久久久蜜桃| 纯流量卡能插随身wifi吗| 国产精品爽爽va在线观看网站| 亚洲电影在线观看av| 国产欧美日韩一区二区三区在线 | 日韩中文字幕视频在线看片 | 麻豆成人午夜福利视频| 久久99热这里只有精品18| 国产精品99久久久久久久久| 国产精品一区www在线观看| 国产成人免费观看mmmm| 日本黄色日本黄色录像| 免费黄色在线免费观看| 国产精品人妻久久久影院| 性高湖久久久久久久久免费观看| 国产乱来视频区| 2018国产大陆天天弄谢| 国产av精品麻豆| 欧美 日韩 精品 国产| 国产亚洲最大av| 国产av码专区亚洲av|